Langland

We believe in the power of different perspectives. It's why we have brought together four key health disciplines - Clinical Trial Experience, Medical Strategy & Education, Public Relations & Policy and Advertising.

This close collaboration allows our clients to have the very best minds in health caring for the most important parts of their business.

LANGLAND TAKES HOME FOUR TROPHIES AT THE 2022 COMMUNIQUÉ AWARDS

LANGLAND WELCOMES MIKE BRIGHTLEY TO ITS ADVERTISING TEAM

Publicis Health UK Launches Unique Agency Offering for Clients Under Langland

Move strengthens market position, simplifying access to Talent spanning the four interconnect disciplines of Clinical Trial Experience, Medical Strategy & Education, Public Relations & Policy and Advertising.

How can we strike the right balance between familiarity and innovation when it comes to data presentation?

Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the session and bringing in broader perspectives from across the Langland team. In our MedComms Networking webinar last month (https://lnkd.in/dN5tHkf), Drew Owen, Diane Ross and I reviewed communications throughout the COVID pandemic to discuss what we felt they taught us about good healthcare communications practice

Fear or encouragement, which is best to drive behaviour change?

The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked, it can lead to a negative build-up of emotion that could be counter-productive to the original intent. Here we discuss fear and encouragement as communication tactics.

Preparing Science for the Real World

Being good at science communication is more than just having a science degree. It’s about truly understanding the real-world context of facts and data.

Travel in the time of COVID

A new era of responsible travel is on the horizon. What can the aviation industry be doing to lead responsibly in a post pandemic world?

The UK has approved the first vaccine for COVID-19. What now?

The authorisation of Pfizer/BioNtech's mRNA vaccine by the MHRA is great news, but no-one has ever tried to roll out a vaccine as rapidly as this one, so we have some challenges to overcome.

Clinical trials and the diversity principle

If they were ever really hidden, 2020 revealed the expensive-sounding problems limiting diversity in clinical trials. Solutions are overdue.